Bortezomib for Injection (Bortenat Injection) is a medication used in the treatment of certain types of cancer, particularly multiple myeloma and mantle cell lymphoma. It belongs to a class of medications known as proteasome inhibitors. Bortezomib works by interfering with the growth and spread of cancer cells in the body.
This medication is typically administered intravenously (into a vein) by a healthcare professional in a clinic or hospital setting. It may be given alone or in combination with other cancer medications as part of a chemotherapy regimen.
Common side effects of bortezomib may include nausea, diarrhea, constipation, fatigue, peripheral neuropathy (numbness or tingling in the hands and feet), low blood cell counts, and fever. Your healthcare provider will monitor you closely for any potential side effects and adjust your treatment regimen as needed.
Its important to follow your healthcare providers instructions carefully while receiving bortezomib treatment and to report any unusual or severe side effects promptly. Additionally, discuss any concerns or questions you have about this medication with your healthcare provider or pharmacist.
Specifications:
1. Brand: Bortenat
2. Composition: Bortezomib
3. Manufacturer: Natco
4. Treatment: Anti-cancer
5. Packaging Size: 1 Vial
6. Form: Injection